Latest news
Greenstone Biosciences Receives NIH Grant To Develop Cardiac Fibrosis Treatments For Duchenne Muscular Dystrophy - pulse2.compulse2.com · Fri, 07 Aug 2026 12:48:12 GMTGreenstone Biosciences Receives NIH R61 Grant to Advance Cardiac Fibrosis Therapeutics for Duchenne Muscular Dystrophy - Business WireBusiness Wire · Thu, 06 Aug 2026 23:35:00 GMTIPS HEART Secures 8th FDA Regulatory Milestone with Rare Pediatric Drug Designation for Cardiomyopathy Associated with Muscular Dystrophies - Business WireBusiness Wire · Thu, 06 Aug 2026 12:11:00 GMTIQVIA Partners With Medera on Cardiac Gene Therapy Development - The Clinical Trial VanguardThe Clinical Trial Vanguard · Wed, 05 Aug 2026 07:37:44 GMTCardiomyopathy in Duchenne muscular dystrophy is focus of nearly $2M grant - news.vumc.orgnews.vumc.org · Tue, 04 Aug 2026 13:36:16 GMTStockWatch: Capricor Plunges as FDA Panel, Staff Question Effectiveness of Lead Candidate Deramiocel - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Mon, 03 Aug 2026 00:49:26 GMTCapricor Therapeutics: FDA Advisory Panel Votes 9-3 That Evidence Does Not Support Deramiocel for DMD Cardiomyopathy - TradingViewTradingView · Thu, 30 Jul 2026 20:13:04 GMTFDA Advisory Panel Skeptical on CAPR's Duchenne Cardiomyopathy T - GuruFocusGuruFocus · Thu, 30 Jul 2026 09:22:30 GMT